AustraliaResearchers at the Women and Infants Research Foundation (WIRF) in Perth, Australia, are developing an artificial placenta to support extremely preterm infants who are born at 22 or 23 weeks gestation. These babies are often underdeveloped and face significant health risks due to incomplete lung development and fragile skin. The artificial placenta aims to provide these infants with additional time to grow and mature in an environment similar to the womb, helping them transition to independent breathing and feeding. The technology uses the fetus’s own heartbeat to power the system, eliminating the need for external pumps. While currently tested on sheep, the goal is eventual application in human neonatal care. This research also enhances understanding of how natural placentas function.
Bias read (Center): The article discusses scientific research focused on medical innovation for preterm infants. There is no political framing, controversy, or ideological emphasis present. The content remains strictly factual and centered on technological advancement in healthcare.
